✦ LIBER ✦

S5-5 PET/CT FOR VULNERABLE ATHEROSCLEROSIS PLAQUE IMAGING

✍ Scribed by Yen-Wen Wu

Book ID: 117353093
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 57 KB
Volume: 122
Category: Article
ISSN: 0167-5273
DOI: 10.1016/s0167-5273(08)70321-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imaging of vulnerable atherosclerotic pl

Imaging of vulnerable atherosclerotic plaque with [18F]FDG-PET: an animal atherosclerosis model study

✍ Mikako Ogawa; Takahiro Mukai; Seigo Ishino; Noboru Teramoto; Hiroshi Watabe; Nob 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

What is the natural history of 18F-FDG u

What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque

✍ Leon J. Menezes; Irfan Kayani; Simona Ben-Haim; Brian Hutton; Peter J. Ell; Ashl 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Evaluation of 5-(2-(4-pyridinyl)vinyl)-6

Evaluation of 5-(2-(4-pyridinyl)vinyl)-6-chloro-3-(1-methyl-2-(S)-pyrrolidinylmethoxy)pyridine and its analogues as PET radioligands for imaging nicotinic acetylcholine receptors

✍ LaVerne Brown; Svetlana Chefer; Olga Pavlova; D. Bruce Vaupel; Andrei O. Koren; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB

Synthesis and biological evaluation of S

Synthesis and biological evaluation of S-[11C]methylated mercaptoimidazole piperazinyl derivatives as potential radioligands for imaging 5-HT1A receptors by positron emission tomography (PET)

✍ Raquel Garcia; Catarina Xavier; António Paulo; Isabel Santos; Torsten Kniess; R. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 157 KB

The novel 2-mercaptoimidazole derivatives, 1-[4-((2-methoxyphenyl)-1-piperazinyl)butyl]-2-mercaptoimidazole (3) and methyl[4-((2-methoxyphenyl)-1-piperazinyl))butyl] (2-mercapto-1-methylimidazol-5-yl)methanamide ( 8), were efficiently labelled with 11 C through methylation of the thioketone function

Radiosynthesis of (S)-5-methoxymethyl-3-

Radiosynthesis of (S)-5-methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl] oxazolidin-2-[11C]one ([11C]SL25.1188), a novel radioligand for imaging monoamine oxidase-B with PET

✍ Yann Bramoullé; Frédéric Puech; Wadad Saba; Heric Valette; Michel Bottlaender; P 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 156 KB

## Abstract Within a novel series of 2‐oxazolidinones developed in the past by Sanofi‐Synthélabo, SL25.1188 ((__S__)‐5‐methoxymethyl‐3‐[6‐(4,4,4‐trifluorobutoxy)benzo[__d__]isoxazol‐3‐yl]oxazolidin‐2‐one), a compound that inhibits selectively and competitively MAO‐B in human and rat brain (Ki value